A3P Barrier Technologies - Lyophilization

Isolators, RABS, Lyophilization, Biological & Enzymatic Indicators, Indirect product contact surfaces, Gloves, Campaign, URS & Design

A3P Barrier Technologies - Lyophilization

When?

February 4 & 5, 2026

Where?

Lyon, France

Format?

Conferences, Partner Sessions & Exhibition

Introduction

Digitalization: Are humans the solution or the problem?
In the age of artificial intelligence and SaaS, we are constantly seeking to optimize our processes for greater efficiency and compliance. But in this race for technology, what is the true place of humans?
Come explore this essential question with members of the GIC A3P ecompliance during these days dedicated to the challenges of digitalization. From electronic data review to AI validation, cybersecurity, and augmented reality training, humans will be the common thread throughout our discussions.
We will open the debate by asking ourselves: “How can we integrate humans into IT processes?”
And we will conclude with a round table discussion that will crystallize our thinking: “Should we remove humans to be more efficient and compliant?”
Join us for two days of sharing and reflection led by our A3P group of experts specializing in IT system compliance on the challenges and opportunities of digitalization, always keeping humans at the center. Together, let's rethink the pharmaceutical industry—your vision is essential!

Official conference language: French 
Simultaneous translation: English

PROGRAM

Related articles

Barrier Technologies & Revision of Annex 1: requirements & operational responses for manufacturers

La Vague 76 / January 2023
CAPA processing is at the heart of the quality system. However, its implementation is difficult on a daily basis, both for the manufacturing laboratory and for its subcontractors and suppliers. The use of an e-QMS is an undeniable advantage in preventing the main deviations encountered. Here we detail these deviations, as well as the advantages and disadvantages of subscription-based or locally installed e-QMS solutions.

GMP Annex 1 and Lyophilization

La Vague 76 / october 2024
Since the publication of the update to Annex 1 of Good Manufacturing Practices (GMP) in 2022, Contamination Control Strategy (CCS) has been the focus of attention. This article reviews its structure, details the use of certain guidelines and the use of feedback to implement a clear and effective CCS and support good contamination control.

Introduction to ASTM E3263-20 "Standard Practice For Qualification Of Visual Inspection of Pharmaceutical Manufacturing Equipment And Medical Devices For Residues"

La Vague 69 / April 2021
Visual inspection has been widely used for many years after equipment cleaning by the pharmaceutical, biotechnology, and medical device industries to release equipment and devices. However, visual inspection has never been proven to be an effective, reliable, or safe method to use.